Tropical Spastic Paraparesis Global Clinical Trials Review, H2, 2016
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Provides top level analysis of <strong>Global</strong> <strong>Clinical</strong> <strong>Trials</strong> Market which helps in identifying key<br />
business opportunities<br />
Supports understanding of trials count and enrollment trends by country in global<br />
therapeutics market<br />
Aids in interpreting the success rates of clinical trials by providing a comparative scenario<br />
of completed and uncompleted (terminated, suspended or withdrawn) trials<br />
Facilitates clinical trial assessment of the indication on a global, regional and country level<br />
Follow us on LinkedIn: https://www.linkedin.com/company/marketresearchreportsbiz<br />
Table of Contents<br />
Table of Contents 2<br />
List of Tables 3<br />
List of Figures 3<br />
Report Guidance 4<br />
<strong>Clinical</strong> <strong>Trials</strong> by Region 5<br />
<strong>Clinical</strong> <strong>Trials</strong> and Average Enrollment by Country 6<br />
Top Countries Contributing to <strong>Clinical</strong> <strong>Trials</strong> in AsiaPacific 8<br />
Top Countries Contributing to <strong>Clinical</strong> <strong>Trials</strong> in Europe 9<br />
Top Countries Contributing to <strong>Clinical</strong> <strong>Trials</strong> in North America 10<br />
Top Countries Contributing to <strong>Clinical</strong> <strong>Trials</strong> in Middle East and Africa 11<br />
Top Countries Contributing to <strong>Clinical</strong> <strong>Trials</strong> in Central and South America 12<br />
<strong>Clinical</strong> <strong>Trials</strong> by G7 Countries: Proportion of <strong>Tropical</strong> <strong>Spastic</strong> <strong>Paraparesis</strong> to Central<br />
Nervous System <strong>Clinical</strong> <strong>Trials</strong> 13<br />
<strong>Clinical</strong> <strong>Trials</strong> by Phase in G7 Countries 14<br />
<strong>Clinical</strong> <strong>Trials</strong> in G7 Countries by Trial Status 15<br />
<strong>Clinical</strong> <strong>Trials</strong> by E7 Countries: Proportion of <strong>Tropical</strong> <strong>Spastic</strong> <strong>Paraparesis</strong> to Central<br />
Nervous System <strong>Clinical</strong> <strong>Trials</strong> 16<br />
<strong>Clinical</strong> <strong>Trials</strong> by Phase 17<br />
In Progress <strong>Trials</strong> by Phase 18<br />
<strong>Clinical</strong> <strong>Trials</strong> by Trial Status 19<br />
<strong>Clinical</strong> <strong>Trials</strong> by End Point Status 20<br />
<strong>Clinical</strong> <strong>Trials</strong> by Sponsor Type 21<br />
Prominent Sponsors 22<br />
Top Companies Participating in <strong>Tropical</strong> <strong>Spastic</strong> <strong>Paraparesis</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> 23<br />
Prominent Drugs 24<br />
<strong>Clinical</strong> Trial Profile Snapshots 25<br />
Appendix 36<br />
Abbreviations 36<br />
Definitions 36<br />
Research Methodology 37<br />
Secondary Research 37<br />
About <strong>Global</strong>Data 38<br />
Contact Us 38<br />
Disclaimer 38<br />
Source 39<br />
About us